1. Home
  2. APLT vs AMSF Comparison

APLT vs AMSF Comparison

Compare APLT & AMSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • AMSF
  • Stock Information
  • Founded
  • APLT 2016
  • AMSF 1985
  • Country
  • APLT United States
  • AMSF United States
  • Employees
  • APLT N/A
  • AMSF N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • AMSF Accident &Health Insurance
  • Sector
  • APLT Health Care
  • AMSF Finance
  • Exchange
  • APLT Nasdaq
  • AMSF Nasdaq
  • Market Cap
  • APLT 971.6M
  • AMSF 968.5M
  • IPO Year
  • APLT 2019
  • AMSF 2005
  • Fundamental
  • Price
  • APLT $9.63
  • AMSF $54.71
  • Analyst Decision
  • APLT Strong Buy
  • AMSF Buy
  • Analyst Count
  • APLT 5
  • AMSF 2
  • Target Price
  • APLT $12.50
  • AMSF $59.50
  • AVG Volume (30 Days)
  • APLT 1.6M
  • AMSF 123.5K
  • Earning Date
  • APLT 11-15-2024
  • AMSF 10-23-2024
  • Dividend Yield
  • APLT N/A
  • AMSF 8.21%
  • EPS Growth
  • APLT N/A
  • AMSF N/A
  • EPS
  • APLT N/A
  • AMSF 3.21
  • Revenue
  • APLT N/A
  • AMSF $315,182,000.00
  • Revenue This Year
  • APLT N/A
  • AMSF N/A
  • Revenue Next Year
  • APLT $3,358.27
  • AMSF N/A
  • P/E Ratio
  • APLT N/A
  • AMSF $17.00
  • Revenue Growth
  • APLT N/A
  • AMSF 2.81
  • 52 Week Low
  • APLT $1.79
  • AMSF $41.97
  • 52 Week High
  • APLT $9.71
  • AMSF $56.46
  • Technical
  • Relative Strength Index (RSI)
  • APLT 67.27
  • AMSF 63.31
  • Support Level
  • APLT $8.38
  • AMSF $53.17
  • Resistance Level
  • APLT $9.29
  • AMSF $55.28
  • Average True Range (ATR)
  • APLT 0.55
  • AMSF 1.14
  • MACD
  • APLT -0.01
  • AMSF 0.13
  • Stochastic Oscillator
  • APLT 84.77
  • AMSF 61.54

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About AMSF AMERISAFE Inc.

AMERISAFE Inc is a specialty provider of workers' compensation insurance to employers engaged in hazardous industries, mainly construction, trucking, manufacturing, oil and gas, and agriculture. The company generates a majority of its revenue in the form of premiums.

Share on Social Networks: